Performance of PTCT PTC Therapeutics | 130.4% in 12m
Compare PTCT with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare PTC Therapeutics with its related Sector/Index XBI
Performance Duell PTCT vs XBI
TimeFrame | PTCT | XBI |
---|---|---|
1 Week | 8.09% | 0.35% |
1 Month | 14.6% | 0.06% |
3 Months | 30.7% | -1.76% |
6 Months | 32.2% | 15.33% |
12 Months | 130.4% | 48.94% |
YTD | 51.6% | 9.31% |
Rel. Perf. 1m | 1.15 | |
Rel. Perf. 3m | 0.74 | |
Rel. Perf. 6m | 1.47 | |
Rel. Perf. 12m | 4.33 | |
Spearman 1m | 0.73 | 0.319 |
Spearman 3m | 0.86 | 0.085 |
Is PTC Therapeutics a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, PTC Therapeutics is currently (October 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 0.26 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PTCT as of October 2024 is 53.90. This means that PTCT is currently undervalued and has a potential upside of +26.82% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PTCT as of October 2024 is 53.90. This means that PTCT is currently undervalued and has a potential upside of +26.82% (Margin of Safety).
Is PTCT a buy, sell or hold?
- Strong Buy: 6
- Buy: 1
- Hold: 6
- Sell: 2
- Strong Sell: 1
Values above 0%: PTCT is performing better - Values below 0%: PTCT is underperforming
Compare PTCT with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 8.36% | 13.16% | 17.45% | 90.84% |
US NASDAQ 100 | QQQ | 7.24% | 12.08% | 16.31% | 89.27% |
US Dow Jones Industrial 30 | DIA | 9.68% | 14.67% | 21.23% | 101.09% |
German DAX 40 | DAX | 7.53% | 17.07% | 24.40% | 98.42% |
Shanghai Shenzhen CSI 300 | CSI 300 | 9.41% | 18.02% | 21.52% | 116.89% |
Hongkong Hang Seng | HSI | 7.70% | 17.72% | 18.56% | 117.68% |
India NIFTY 50 | INDA | 8.72% | 20.18% | 27.07% | 103.07% |
Brasil Bovespa | EWZ | 7.70% | 18.90% | 40.45% | 131.93% |
PTCT PTC Therapeutics vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 7.47% | 12.98% | 16.10% | 87.54% |
Consumer Discretionary | XLY | 6.41% | 14.34% | 19.94% | 96.93% |
Consumer Staples | XLP | 8.51% | 16.74% | 23.75% | 107.31% |
Energy | XLE | 9.06% | 12.25% | 38.18% | 122.04% |
Financial | XLF | 8.15% | 10.00% | 15.53% | 82.07% |
Health Care | XLV | 9.76% | 17.31% | 25.45% | 108.97% |
Industrial | XLI | 10.24% | 13.84% | 21.52% | 90.17% |
Materials | XLB | 10.30% | 16.81% | 26.31% | 103.30% |
Real Estate | XLRE | 7.20% | 14.74% | 10.25% | 92.10% |
Technology | XLK | 8.85% | 12.29% | 17.11% | 88.94% |
Utilities | XLU | 8.85% | 13.83% | 9.68% | 90.16% |
Aerospace & Defense | XAR | 10.87% | 12.91% | 15.88% | 91.02% |
Biotech | XBI | 7.74% | 14.50% | 16.90% | 81.41% |
Homebuilder | XHB | 11.26% | 19.80% | 19.24% | 64.93% |
Retail | XRT | 8.92% | 16.37% | 27.11% | 98.38% |
Does PTC Therapeutics outperform its market, is PTCT a Sector Leader?
Yes, over the last 12 months PTC Therapeutics (PTCT) made 130.35%, while its related Sector, the SPDR S&P Biotech (XBI) made 48.94%.
Over the last 3 months PTCT made 30.69%, while XBI made -1.76%.
Yes, over the last 12 months PTC Therapeutics (PTCT) made 130.35%, while its related Sector, the SPDR S&P Biotech (XBI) made 48.94%.
Over the last 3 months PTCT made 30.69%, while XBI made -1.76%.
Period | PTCT | XBI | S&P 500 |
---|---|---|---|
1 Month | 14.56% | 0.06% | 1.40% |
3 Months | 30.69% | -1.76% | 7.12% |
12 Months | 130.35% | 48.94% | 39.51% |